Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Remick

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
American Journal of Medical Genetics|June 15, 1994
Mood Disorder Service Genetic Database: morbidity risks for mood disorders in 3,942 first-degree relatives of 671 index cases with single depression, recurrent depression, bipolar I, or bipolar IIA D Sadovnick, R A Remick, R Lam, et al.
Molecular Psychiatry|February 13, 2002
Segmental linkage disequilibrium within the dopamine transporter geneT A Greenwood, M Alexander, P E Keck, et al.
The Journal of Clinical Psychiatry|May 1, 1983
A comparative study of bupropion and amitriptyline in depressed outpatientsJ Mendels, M M Amin, G Chouinard, et al.
Molecular Psychiatry|June 17, 2003
Linkage of a bipolar disorder susceptibility locus to human chromosome 13q32 in a new pedigree seriesS H Shaw, Z Mroczkowski-Parker, T Shekhtman, et al.
American Journal of Medical Genetics|November 22, 1996
Possible locus for bipolar disorder near the dopamine transporter on chromosome 5J R Kelsoe, A D Sadovnick, H Kristbjarnarson, et al.
Clinical Neuropharmacology|January 1, 1993
Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studiesG Chouinard, B M Saxena, N P Nair, et al.
Journal of Affective Disorders|October 1, 1994
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depressionG Chouinard, B M Saxena, N P Nair, et al.
Clinical Neuropharmacology|January 1, 1992
Efficacy and safety of brofaromine in depression: a Canadian multicenter placebo controlled trial and a review of comparative controlled studiesG Chouinard, B M Saxena, N P Nair, et al.
American Journal of Medical Genetics|April 18, 1997
Linkage studies suggest a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22H M Lachman, J R Kelsoe, R A Remick, et al.
Molecular Psychiatry|June 17, 2003
Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorderT B Barrett, R L Hauger, J L Kennedy, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
American Journal of Medical Genetics|June 15, 1994
Mood Disorder Service Genetic Database: morbidity risks for mood disorders in 3,942 first-degree relatives of 671 index cases with single depression, recurrent depression, bipolar I, or bipolar IIA D Sadovnick, R A Remick, R Lam, et al.
Molecular Psychiatry|February 13, 2002
Segmental linkage disequilibrium within the dopamine transporter geneT A Greenwood, M Alexander, P E Keck, et al.
The Journal of Clinical Psychiatry|May 1, 1983
A comparative study of bupropion and amitriptyline in depressed outpatientsJ Mendels, M M Amin, G Chouinard, et al.
Molecular Psychiatry|June 17, 2003
Linkage of a bipolar disorder susceptibility locus to human chromosome 13q32 in a new pedigree seriesS H Shaw, Z Mroczkowski-Parker, T Shekhtman, et al.
American Journal of Medical Genetics|November 22, 1996
Possible locus for bipolar disorder near the dopamine transporter on chromosome 5J R Kelsoe, A D Sadovnick, H Kristbjarnarson, et al.
Clinical Neuropharmacology|January 1, 1993
Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studiesG Chouinard, B M Saxena, N P Nair, et al.
Journal of Affective Disorders|October 1, 1994
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depressionG Chouinard, B M Saxena, N P Nair, et al.
Clinical Neuropharmacology|January 1, 1992
Efficacy and safety of brofaromine in depression: a Canadian multicenter placebo controlled trial and a review of comparative controlled studiesG Chouinard, B M Saxena, N P Nair, et al.
American Journal of Medical Genetics|April 18, 1997
Linkage studies suggest a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22H M Lachman, J R Kelsoe, R A Remick, et al.
Molecular Psychiatry|June 17, 2003
Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorderT B Barrett, R L Hauger, J L Kennedy, et al.
Pageof 9